CIK 0001861107
- Non-accelerated filer
- Smaller reporting company
- Emerging growth company
Ceribell, Inc.
Sign in to watch- Ticker
- CBLL
- Exchange
- Nasdaq
- Industry
- Electromedical & Electrotherapeutic Apparatus
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 471785452
- Phone
- +1 800-436-0826
- Business address
- 360 N. PASTORIA AVENUE, SUNNYVALE, CA, 94085
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $3,554,752
- in 12 filings, $3.3M under 10b5-1 plans
Net −$3,554,752. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-09-15 | Blumberg Scott Chief Financial Officer | Exercise or conversion 10b5-1 | +846 | $9.41 | $8K | 147,446 |
| 2026-09-15 | Blumberg Scott Chief Financial Officer | Sale 10b5-1 | −846 | $25.00 | $21K | 146,600 |
| 2026-09-15 | Blumberg Scott Chief Financial Officer | Exercise or conversion · Stock Option (Right to Buy) 10b5-1 | −846 | 51,802 | ||
| 2026-09-02 | Blumberg Scott Chief Financial Officer | Exercise or conversion 10b5-1 | +652 | $9.41 | $6K | 147,252 |
| 2026-09-02 | Blumberg Scott Chief Financial Officer | Sale 10b5-1 | −652 | $25.00 | $16K | 146,600 |
| 2026-09-02 | Blumberg Scott Chief Financial Officer | Exercise or conversion · Stock Option (Right to Buy) 10b5-1 | −652 | 52,648 | ||
| 2026-08-21 | Blumberg Scott Chief Financial Officer | Sale | −1,521 | $24.02 | $37K | 146,600 |
| 2026-08-19 | Blumberg Scott Chief Financial Officer | Exercise or conversion 10b5-1 | +6,179 | $4.70 | $29K | 154,300 |
| 2026-08-19 | Blumberg Scott Chief Financial Officer | Exercise or conversion 10b5-1 | +27,333 | $9.41 | $257K | 181,633 |
| 2026-08-19 | Blumberg Scott Chief Financial Officer | Sale 10b5-1 | −33,512 | $25.03 | $839K | 148,121 |
| 2026-08-19 | Blumberg Scott Chief Financial Officer | Exercise or conversion · Stock Option (Right to Buy) 10b5-1 | −6,179 | 37,224 | ||
| 2026-08-19 | Blumberg Scott Chief Financial Officer | Exercise or conversion · Stock Option (Right to Buy) 10b5-1 | −27,333 | 53,300 | ||
| 2026-08-18 | Blumberg Scott Chief Financial Officer | Exercise or conversion 10b5-1 | +690 | $4.70 | $3K | 148,811 |
| 2026-08-18 | Blumberg Scott Chief Financial Officer | Exercise or conversion 10b5-1 | +300 | $9.41 | $3K | 149,111 |
| 2026-08-18 | Blumberg Scott Chief Financial Officer | Sale 10b5-1 | −990 | $25.00 | $25K | 148,121 |
| 2026-08-18 | Blumberg Scott Chief Financial Officer | Exercise or conversion · Stock Option (Right to Buy) 10b5-1 | −690 | 43,403 | ||
| 2026-08-18 | Blumberg Scott Chief Financial Officer | Exercise or conversion · Stock Option (Right to Buy) 10b5-1 | −300 | 80,633 | ||
| 2026-05-21 | Blumberg Scott Chief Financial Officer | Sale | −1,387 | $18.00 | $25K | 147,683 |
| 2026-04-01 | Blumberg Scott Chief Financial Officer | Grant or award | +30,736 | 149,070 | ||
| 2026-04-01 | Blumberg Scott Chief Financial Officer | Grant or award · Stock Option (Right to Buy) | +51,227 | 51,227 |
Page 1 of 2 · 39 trades